Huaiwu Lu

776 total citations
54 papers, 492 citations indexed

About

Huaiwu Lu is a scholar working on Obstetrics and Gynecology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Huaiwu Lu has authored 54 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Obstetrics and Gynecology, 17 papers in Molecular Biology and 15 papers in Reproductive Medicine. Recurrent topics in Huaiwu Lu's work include Endometrial and Cervical Cancer Treatments (21 papers), Ovarian cancer diagnosis and treatment (15 papers) and Cervical Cancer and HPV Research (7 papers). Huaiwu Lu is often cited by papers focused on Endometrial and Cervical Cancer Treatments (21 papers), Ovarian cancer diagnosis and treatment (15 papers) and Cervical Cancer and HPV Research (7 papers). Huaiwu Lu collaborates with scholars based in China, Hong Kong and United States. Huaiwu Lu's co-authors include Zhongqiu Lin, Dongyan Wang, Yunyun Liu, Hui Zhou, Jing Li, Shengpeng Wang, Lingling Xie, Yingqi Xu, Yuefei Yu and Hon Fai Chan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Huaiwu Lu

47 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huaiwu Lu China 12 221 186 130 106 85 54 492
Namiko Yada-Hashimoto Japan 9 244 1.1× 134 0.7× 127 1.0× 106 1.0× 65 0.8× 10 551
Jole Ventriglia Italy 13 111 0.5× 369 2.0× 125 1.0× 52 0.5× 128 1.5× 36 547
Wenyan Wang China 16 232 1.0× 90 0.5× 177 1.4× 68 0.6× 86 1.0× 44 541
Marten van der Zee Netherlands 13 206 0.9× 104 0.6× 97 0.7× 149 1.4× 189 2.2× 15 552
Weiguo Lü China 10 133 0.6× 169 0.9× 75 0.6× 37 0.3× 60 0.7× 25 403
Şeyda Karaveli Türkiye 10 187 0.8× 56 0.3× 76 0.6× 71 0.7× 50 0.6× 34 385
K. Oliva Australia 8 120 0.5× 164 0.9× 67 0.5× 80 0.8× 67 0.8× 13 431
Vanessa Costa Miranda Brazil 6 136 0.6× 147 0.8× 48 0.4× 69 0.7× 17 0.2× 11 298
Canhui Jin China 13 334 1.5× 113 0.6× 262 2.0× 21 0.2× 36 0.4× 16 494
Liangdan Tang China 15 220 1.0× 61 0.3× 90 0.7× 168 1.6× 33 0.4× 35 524

Countries citing papers authored by Huaiwu Lu

Since Specialization
Citations

This map shows the geographic impact of Huaiwu Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaiwu Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaiwu Lu more than expected).

Fields of papers citing papers by Huaiwu Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huaiwu Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaiwu Lu. The network helps show where Huaiwu Lu may publish in the future.

Co-authorship network of co-authors of Huaiwu Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Huaiwu Lu. A scholar is included among the top collaborators of Huaiwu Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huaiwu Lu. Huaiwu Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Haixia, Jianqing Zhu, Dongling Zou, et al.. (2025). Multicenter study of ovarian cancer score for diagnosing ovarian cancer. Gynecologic Oncology. 193. 58–64. 1 indexed citations
2.
Zhao, Haibo, et al.. (2024). Metastatic pericardial mass and cardiophrenic lymph nodes resection in ovarian cancer. Gynecologic Oncology Reports. 53. 101385–101385.
4.
Liu, Yunyun, Meng Xia, Zhibo Chen, et al.. (2024). HNRNPC mediates lymphatic metastasis of cervical cancer through m6A-dependent alternative splicing of FOXM1. Cell Death and Disease. 15(10). 732–732. 4 indexed citations
5.
Lu, Huaiwu, et al.. (2024). Advances in management algorithm in clear cell carcinoma of cervix. SHILAP Revista de lepidopterología. 3(1). 1 indexed citations
6.
Wu, Jingxiang, Dongdong Ye, Shaolin Ma, et al.. (2024). New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer. BMC Cancer. 24(1). 1536–1536.
7.
Lu, Huaiwu, Ying Zhou, Xiaoran Long, et al.. (2023). Development and external validation of nomograms for predicting individual survival in patients with ovarian clear cell carcinoma. Cancer Medicine. 12(10). 11385–11395. 1 indexed citations
9.
Zhou, Ying, Shuangfeng Chen, Huaiwu Lu, et al.. (2023). An analysis of clinical characteristics and prognosis of endometrioid ovarian cancer based on the SEER database and two centers in China (1112). Gynecologic Oncology. 176. S85–S85. 1 indexed citations
10.
Li, Qunxing, Lizao Zhang, Binghui Zeng, et al.. (2023). Mutational landscape of head and neck cancer and cervical cancer in Chinese and Western population. Head & Neck. 46(3). 528–540. 2 indexed citations
11.
Han, Xue, Hui Zhou, Yajie Gong, et al.. (2022). Novel prognostic nomograms in cervical cancer based on analysis of 1075 patients. Cancer Medicine. 12(5). 6092–6104. 2 indexed citations
12.
Liu, Yunyun, et al.. (2022). Round ligament suspension and vaginal purse‐string suture: Newly optimized techniques to prevent tumor spillage in laparoscopic radical trachelectomy for cervical cancer. Journal of obstetrics and gynaecology research. 48(7). 1867–1875. 2 indexed citations
13.
Liu, Yunyun, et al.. (2022). Genomic and expressional dynamics of ovarian cancer cell lines in PARPi treatment revealed mechanisms of acquired resistance. Gynecologic Oncology. 167(3). 502–512. 5 indexed citations
15.
Feng, Xiaoyan, Huaiwu Lu, Wei Yuan, et al.. (2021). Prognostic impact of hepatitis B virus infection in patients with primary cervical cancer. Cancer Medicine. 10(23). 8310–8319. 10 indexed citations
16.
Zhang, Yi, Minhua Yu, Ying Jing, et al.. (2020). Baseline immunity and impact of chemotherapy on immune microenvironment in cervical cancer. British Journal of Cancer. 124(2). 414–424. 50 indexed citations
17.
Zheng, Xin, Shulin Chen, Linfang Li, et al.. (2018). Evaluation of HE4 and TTR for diagnosis of ovarian cancer: Comparison with CA-125. Journal of Gynecology Obstetrics and Human Reproduction. 47(6). 227–230. 31 indexed citations
18.
Xu, Yingqi, Shengpeng Wang, Hon Fai Chan, et al.. (2017). Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of Survivin. Scientific Reports. 7(1). 46060–46060. 51 indexed citations
19.
Lu, Huaiwu, et al.. (2015). Can radical parametrectomy be omitted in occult cervical cancer after extrafascial hysterectomy?. Chinese Journal of Cancer. 34(3). 413–9. 6 indexed citations
20.
Lu, Huaiwu. (2005). On English Teaching Reform in Higher Vocational Colleges. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026